Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com//news-release/2024/01/24/2815093/0/en/Amphista-Therapeutics-announces-new-data-demonstrating-in-vivo-efficacy-and-CNS-activity-of-its-mechanistically-differentiated-targeted-protein-degraders.html
https://www.globenewswire.com//news-release/2024/01/24/2814809/0/en/Amphista-Therapeutics-announces-new-data-demonstrating-in-vivo-efficacy-and-CNS-activity-of-its-mechanistically-differentiated-targeted-protein-degraders.html
https://www.fiercebiotech.com/research/amphista-claims-its-targeted-protein-degraders-have-rapid-efficacy-against-tumor-and-cns
https://www.globenewswire.com//news-release/2023/09/26/2749658/0/en/Amphista-Therapeutics-Achieves-First-Milestone-in-Second-Discovery-Programme-with-Bristol-Myers-Squibb.html
https://www.prnewswire.com/news-releases/amphista-therapeutics-achieves-first-discovery-milestone-in-collaboration-with-bristol-myers-squibb-301815255.html
https://www.prnewswire.com/news-releases/amphista-therapeutics-expands-senior-team-and-announces-appointment-of-louise-modis-as-chief-scientific-officer-and-ian-churcher-as-chief-technology-officer-301812611.html
https://www.prnewswire.com/news-releases/dementia-discovery-fund-invests-in-amphista-therapeutics-as-it-targets-neurodegenerative-diseases-301701097.html
https://www.pharmatimes.com/news/amphista_partners_with_domainex_to_advance_drug_portfolio_1456393
https://www.biospace.com/article/amphista-scores-two-deals-with-big-pharma-worth-over-2b/
https://www.prnewswire.com/news-releases/amphista-therapeutics-appoints-new-chairman-joshua-t-brumm-301380351.html